Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
IMMP similar filings
- 10 Mar 22 Immutep Receives Constructive Feedback from Us Fda on Its
- 24 Feb 22 Immutep Granted Australian Patent for Eftilagimod Alpha, a Soluble LAG-3 Protein, In Combination with a PD-1 Pathway Inhibitor
- 24 Feb 22 Half-Year Financial Report
- 25 Jan 22 Immutep Quarterly Activities Report & Appendix 4C
- 16 Dec 21 Current report (foreign)
- 3 Dec 21 Immutep Reports Good Safety from First Five Patients In Triple Combination Therapy Efti Study, INSIGHT-003
- 22 Nov 21 Immutep Successfully Completes Recruitment for Phase II TACTI-002 Study
Filing view
External links